The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ZEOX · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | TRMB | ZEOX | BEIGF | TMO |
|---|---|---|---|---|
| Moat Score (0–100) | 54 | 55 (highest) | 54 | 54 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 39 | 27 | 80 (highest) | 52 |
| Pricing power | 86 | 70 | 94 (highest) | 94 (highest) |
| Returns on capital | 10 | — | 4 | 23 (highest) |
| Balance-sheet safety | 42 | 78 (highest) | 69 | 25 |
| Capital allocation | 92 (highest) | 44 | 24 | 75 |
| 124% above value if growth stopped today (largest discount to value if growth stopped today) | No price data | No price data | 193% above value if growth stopped today | |
| Market cap | $14.4B | $7.7M | Not reported | $258.7B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2026 | FY2025 | FY2025 |